WELCOME TO VISICORT
Improving the Success Rate of Corneal Transplants
Corneal disease is a leading cause of blindness worldwide and affects individuals of both genders and of all age groups.
- VISICORT is an EU-funded research project to help improve corneal transplant success.
- VISICORT has collected and analyzed more than 50,000 human bio-samples from 5 leading European eye hospitals and clinics.
- The VISICORT Foundation Biobank of bio-specimens will support future research in eye damage and disease.
- VISICORT has manufactured a mesenchymal stromal cell product that will be trialled in people under-going high-risk corneal transplantation at the Charité University Hospital in Berlin as part of a safety and feasibility study to mitigate rejection episodes.
https://visicort.eu/wp-content/uploads/2020/08/Epimune-square.png
1312
1312
visicort_admin
http://visicort.eu/wp-content/uploads/2014/03/visicort_logo_final-300x126.jpg
visicort_admin2020-08-18 11:13:012020-08-31 12:30:43Exploitation news: A collaboration with Epimune GmbH begins
https://visicort.eu/wp-content/uploads/2020/06/INSERM-square.png
800
800
visicort_admin
http://visicort.eu/wp-content/uploads/2014/03/visicort_logo_final-300x126.jpg
visicort_admin2020-08-17 15:36:462020-08-17 15:36:472020 COP&S conference coordinated by VISICORT PI Dr Bertrand Fabres slated for November 12 & 13th
https://visicort.eu/wp-content/uploads/2020/08/download-1-1.png
740
740
visicort_admin
http://visicort.eu/wp-content/uploads/2014/03/visicort_logo_final-300x126.jpg
visicort_admin2020-08-17 13:37:222020-08-17 15:27:14VISICORT presented at Ophthalmology changing event, BerlinProject Partners
News
Project Info
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602470. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.
